ATE348648T1 - Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon - Google Patents

Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon

Info

Publication number: ATE348648T1
Authority: AT; Austria
Prior art keywords: tetracos; trans; acid; apocynine; enene
Prior art date: 2002-03-25

Application number

AT02722566T

Other languages

English (en)

Inventor

Sukhdev Swami Handa

Om Parkash Suri

V N Gupta

Krishan Avtar Suri

Naresh Kumar Satti

Vikram Bhardwaj

Bupinder Singh

Bal Krishan Chandan

Original Assignee

Council Scient Ind Res

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-03-25

Filing date

2002-03-25

Publication date

2007-01-15

2002-03-25 Application filed by Council Scient Ind Res filed Critical Council Scient Ind Res

2007-01-15 Application granted granted Critical

2007-01-15 Publication of ATE348648T1 publication Critical patent/ATE348648T1/de

Links

DFYRUELUNQRZTB-UHFFFAOYSA-N apocynin Chemical compound COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 title abstract 5
230000002195 synergetic effect Effects 0.000 title abstract 2
-1 TRANS-TETRACOS-15-ENENE Chemical group 0.000 title 1
239000002253 acid Substances 0.000 title 1
229930188866 apocynin Natural products 0.000 abstract 2
206010019851 Hepatotoxicity Diseases 0.000 abstract 1
GWHCXVQVJPWHRF-UHFFFAOYSA-N cis-tetracosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-UHFFFAOYSA-N 0.000 abstract 1
230000002443 hepatoprotective effect Effects 0.000 abstract 1
230000007686 hepatotoxicity Effects 0.000 abstract 1
231100000304 hepatotoxicity Toxicity 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
GWHCXVQVJPWHRF-MDZDMXLPSA-N trans-selacholeic acid Chemical compound CCCCCCCC\C=C\CCCCCCCCCCCCCC(O)=O GWHCXVQVJPWHRF-MDZDMXLPSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

Health & Medical Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Botany (AREA)
Mycology (AREA)
Microbiology (AREA)
Medical Informatics (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Plant Substances (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT02722566T 2002-03-25 2002-03-25 Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon ATE348648T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
PCT/IB2002/001212 WO2003080081A2 (en)	2002-03-25	2002-03-25	Synergistic composition of trans-tetracos-15-enoic acid and apocynin and use thereof
EP02722566A EP1509285B1 (de)	2002-03-25	2002-03-25	Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon

Publications (1)

Publication Number	Publication Date
ATE348648T1 true ATE348648T1 (de)	2007-01-15

Family

ID=28053185

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02722566T ATE348648T1 (de)	2002-03-25	2002-03-25	Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon

Country Status (7)

Country	Link
EP (1)	EP1509285B1 (de)
JP (1)	JP4299147B2 (de)
CN (1)	CN1269475C (de)
AT (1)	ATE348648T1 (de)
AU (1)	AU2002253445A1 (de)
DE (1)	DE60216979T2 (de)
WO (1)	WO2003080081A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1602926A1 (de) *	2004-06-04	2005-12-07	University of Geneva	Neue Mittel und Verfahren zur Behandlung von Gehörverlust oder Tinnitus
CN108610285B (zh) *	2017-03-17	2020-04-28	上海柏翱纳吉医药科技有限公司	苯乙酮类化合物、其制备方法及其在防治脂肪肝方面的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6090851A (en) *	1997-09-10	2000-07-18	Johns Hopkins University School Of Medicine	Use of an NADPH-oxidase inhibitor in the treatment of reperfusion injury
US6492429B1 (en) *	2000-07-10	2002-12-10	N.V. Nutricia	Composition for the treatment of osteoarthritis
GB2368012A (en) *	2000-10-19	2002-04-24	Nicholas John Larkins	Preparation for the relief of inflammatory disease

2002
- 2002-03-25 DE DE60216979T patent/DE60216979T2/de not_active Expired - Lifetime
- 2002-03-25 CN CNB02828951XA patent/CN1269475C/zh not_active Expired - Fee Related
- 2002-03-25 AT AT02722566T patent/ATE348648T1/de active
- 2002-03-25 AU AU2002253445A patent/AU2002253445A1/en not_active Abandoned
- 2002-03-25 JP JP2003577907A patent/JP4299147B2/ja not_active Expired - Fee Related
- 2002-03-25 WO PCT/IB2002/001212 patent/WO2003080081A2/en not_active Ceased
- 2002-03-25 EP EP02722566A patent/EP1509285B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO2003080081A2 (en)	2003-10-02
AU2002253445A1 (en)	2003-10-08
WO2003080081A3 (en)	2004-12-23
JP2005526098A (ja)	2005-09-02
EP1509285A2 (de)	2005-03-02
EP1509285B1 (de)	2006-12-20
JP4299147B2 (ja)	2009-07-22
DE60216979D1 (de)	2007-02-01
AU2002253445A8 (en)	2003-10-08
DE60216979T2 (de)	2007-08-30
CN1625422A (zh)	2005-06-08
CN1269475C (zh)	2006-08-16

Similar Documents

Publication	Publication Date	Title
DE602004018338D1 (de)	2009-01-22	Prävention und behandlung von durch entzündung ausgelöstem und/oder immunvermitteltem knochenschwund
SE0301882D0 (sv)	2003-06-25	New use I
SE0301886D0 (sv)	2003-06-25	New use V
DE60236541D1 (de)	2010-07-08	Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
PL375621A1 (pl)	2005-12-12	Kompozycje farmaceutyczne zawierające flawonoidy i mentol
ATE361084T1 (de)	2007-05-15	Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
EA200501268A1 (ru)	2006-02-24	Ингибирующие вич 1,2,4-триазины
EA200501805A1 (ru)	2006-06-30	Фармацевтическая композиция, содержащая ингибитор фермента дипептидилпептидазы
DK1545587T3 (da)	2011-05-09	Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
DK1539166T3 (da)	2008-10-20	Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
DE60330485D1 (de)	2010-01-21	Zur behandlung von diabetes
ATE350375T1 (de)	2007-01-15	17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
EP1505990A4 (de)	2008-02-20	Verfahren zur behandlung von hepatitis
UY27993A1 (es)	2004-03-31	Derivados de 4-pirrolidino-fenil-bencil eter
DE60323765D1 (de)	2008-11-06	Inhibitoren der 17 beta-hydroxysteroiddehydrogenase des typs 3 zur behandlung androgenabhängiger krankheiten
BR0313282A (pt)	2005-10-18	Composições de inibidor seletivo de ciclooxigenase-2 e um inibidor de anidrase carbÈnica para o tratamento de neoplasia
BR0316723A (pt)	2005-10-18	Derivados de anilinopirazol úteis para o tratamento de diabetes
DE69836678D1 (de)	2007-02-01	Chinolin- und chinazolinderivate als antagonisten des corticotropin freisetzenden faktors (crf)
EE200400031A (et)	2004-04-15	Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
ATE516027T1 (de)	2011-07-15	Orazamid orotat zur vorbeugung von leberschäden
DE60128009D1 (de)	2007-05-31	Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
DE60216979D1 (de)	2007-02-01	Synergistische zusammensetzung aus trans-tetracos-15-ensäure und apocynin, und verwendung davon
SE0301883D0 (sv)	2003-06-25	New use II
DK1212072T3 (da)	2004-06-21	Farmaceutisk præparat omfattende eukalyptus- og orangeolie
SE0301885D0 (sv)	2003-06-25	New use IV

Legal Events

Date

Code

Title

Description

2007-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1509285

Country of ref document: EP